Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

por Xu, Jing, Lloyd, David J., Hale, Clarence, Stanislaus, Shanaka, Chen, Michelle, Sivits, Glenn, Vonderfecht, Steven, Hecht, Randy, Li, Yue-Sheng, Lindberg, Richard A., Chen, Jin-Long, Jung, Dae Young, Zhang, Zhiyou, Ko, Hwi Jin, Kim, Jason K., Véniant, Murielle M.
Publicado 2009

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes

por Hecht, Randy, Li, Yue-Sheng, Sun, Jeonghoon, Belouski, Ed, Hall, Michael, Hager, Todd, Yie, Junming, Wang, Wei, Winters, Dwight, Smith, Stephen, Spahr, Chris, Tam, Lei-Ting, Shen, Zhongnan, Stanislaus, Shanaka, Chinookoswong, Narumol, Lau, Yvonne, Sickmier, Allen, Michaels, Mark Leo, Boone, Thomas, Véniant, Murielle M., Xu, Jing
Publicado 2012